You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human epidermal growth factor receptor 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Breast Cancer Invasive Trial (pyrotinib)

Not yet recruiting
  • Breast Cancer Invasive
  • (no location specified)
Jun 18, 2023

HER-2 Expression in Pancreatic Duct Adenocarcinoma

Completed
  • Pancreatic Adenocarcinoma
  • immunohistochemical approach
  • (no location specified)
Sep 20, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Breast Cancer Trial in New York (core needle biopsy, blood draw)

Recruiting
  • Breast Cancer
  • core needle biopsy
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023

Primary Breast Cancer Trial (SPECT)

Not yet recruiting
  • Primary Breast Cancer
  • (no location specified)
Jun 19, 2023

Breast Cancer Trial in Shanghai (Pertuzumab)

Not yet recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine affiliated Ruiji
Jun 4, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • AND019 PO QD
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 19, 2022

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

Active, not recruiting
  • Breast Cancer
  • Amcenestrant (SAR439859)
  • Chuo-Ku, Japan
  • +2 more
Nov 16, 2022

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

Completed
Has Results
  • Adenocarcinoma, Gastric
  • Neoplasm, Breast
  • Taipei, Taiwan
  • +1 more
Nov 2, 2022

HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

Recruiting
  • HER2-negative Early Breast Cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
  • Beijing, China
    Peking University People's Hospital
Mar 27, 2022

Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

Enrolling by invitation
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Olga
Jun 19, 2023

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023